Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
37.16
-2.39 (-6.04%)
At close: May 16, 2025, 4:00 PM
36.00
-1.16 (-3.12%)
After-hours: May 16, 2025, 6:46 PM EDT
Monopar Therapeutics Employees
As of December 31, 2024, Monopar Therapeutics had 16 total employees, including 14 full-time and 2 part-time employees. The number of employees increased by 6 or 60.00% compared to the previous year.
Employees
16
Change (1Y)
6
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$1,035,635
Market Cap
227.14M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
MNPR News
- 4 days ago - Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments - GlobeNewsWire
- 11 days ago - Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025 - GlobeNewsWire
- 18 days ago - Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025 - GlobeNewsWire
- 6 weeks ago - Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments - GlobeNewsWire
- 4 months ago - Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics - PRNewsWire
- 5 months ago - Monopar: Radiopharmaceutical Company With 2 Radioisotope Development Pathways - Seeking Alpha
- 5 months ago - Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants - GlobeNewsWire
- 5 months ago - Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu - GlobeNewsWire